Abstract
1126 Background: Capecitabine is increasingly used in the treatment of metastatic breast cancer (MBC). We evaluated the use of capecitabine therapy (XT) in MBC at our centre, to determine factors t...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
